Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria. J of Skin [Internet]. 2024 Jan. 16 [cited 2026 May 27];8(1):s333. Available from: https://skin.dermsquared.com/skin/article/view/2550